Shannon Macquarrie has over 20 years of experience building and growing global clinical development teams. Within this realm she has developed processes that have implemented technologies that have been applied to strategy implementation through all phases of clinical development from start-up through site close out. Ms. Macquarrie has been responsible for development and roll-out of full operational and risk oversight of clinical programs and product portfolios. She regularly serves on client executive steering and joint oversight governance committees. She is a focused leader and articulate communicator capable of building long lasting relationships with key stake holders at all levels. Ms. Macquarrie’s therapeutic experience is broad and has extensive experience in the oversight of pediatric and cell therapy operating models and has designed initiatives to improve the delivery of oncology and immune-oncology programs.
Paul has been Head of the Radiological, GM, Novel Foods and Feed Additives Team since Jan 2019. He has been with the FSA since its formation in 2000, having previously been in the Ministry of Agriculture, Fisheries and Food (MAFF). He has led on several policy areas of food safety including leading on food defence then Allergy & Intolerance team
Kelly McKee is the Vice President of Patient Registries and Recruitment at Medidata with 20 years of experience in clinical trial operations, patient recruitment and innovation. She is a proven clinical trial leader and trailblazer in operationalizing global patient-focused solutions across organizations including innovations in clinical trial awareness, access, and improvements in patient experiences. Kelly is passionate about celebrating the role that clinical trial participants bring in making new medicines and vaccines possible and was named one of PharmaVoice’s 100 Most Inspiring Leaders in 2020, Centerwatch’s Top 20 Innovators of 2018, and PharmaTimes’ Clinical Researcher of the Year, Clinical Research Teams, in 2012.